Evidence map›Paper›PMID 42059327›Full record

ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Quantum Dots for Biomedical Biosensing, NIR-II Bioimaging, and Phototherapy: Materials Design, Signal Transduction, and Translational Barriers.

Jie Ju, Zhifang Liu, Xinran Gao, Wen Sun, Wei Fu, Yanfei Wang

Abstract readReview
In one paragraph

Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jie JuKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Day Oncology Unit, Peking University Cancer Hospital & Institute, Beijing, China.
Zhifang LiuInstitute of Atomic Manufacturing, Beihang University, Beijing, China.ORCID https://orcid.org/0000-0002-0254-2984
Xinran GaoDepartment of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, China.
Wen SunDepartment of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, China.ORCID https://orcid.org/0000-0002-9209-4889
Wei FuAnhui Province Key Laboratory of Conservation and Utilization for Dabie Mountain Special Bio-Resources, West Anhui University, Lu'an, Anhui, China.
Yanfei WangKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Day Oncology Unit, Peking University Cancer Hospital & Institute, Beijing, China.ORCID https://orcid.org/0000-0003-0300-0287

Funding

Beijing Xisike Clinical Oncology Research Foundation Y-NESTLE2022MS-0228,Y-Young2023-0070Clinical Research Fund for Distinguished Young Scholars of Peking University Cancer Hospital QNJJ2023032National High Level Hospital Clinical Research Funding (Research Achievement Transformation Project of Peking University First Hospital) 2025CX05National Natural Science Foundation of China 62304020Natural Science Foundation of Anhui Province 2408085QB042Science Foundation of Peking University Cancer Hospital ZY202517
6 · The paper itself

Abstract

Quantum dots (QDs) have emerged as standout candidates among inorganic nanomaterials, distinguished by their tunable photoluminescence, exceptional photostability, and size-dependent quantum confinement effects that enable tailored emission from the visible to the near-infrared range. These remarkable optical properties, coupled with broad absorption spectra and high quantum yields, have positioned QDs at the forefront of diverse biomedical applications. This review provides a systematic overview of QDs fabrication strategies, with a focus on bottom-up approaches, such as colloidal synthesis, hydrothermal, and solvothermal methods, as well as emerging biomimetic synthesis inspired by natural biomineralization. Additionally, we offer an in-depth discussion of cutting-edge QDs applications across three key areas: high-sensitivity biosensing for biomarker detection and point-of-care diagnostics; bioimaging, including fluorescence, magnetic resonance, and photoacoustic imaging; and intelligent nanocarrier-based cancer therapeutics, encompassing targeted drug delivery and imaging-guided precision surgery. Furthermore, this review examines the key challenges and optimization strategies for QDs in biomedical applications, with a particular focus on the critical bottlenecks impeding their clinical translation. By analyzing these barriers and outlining future directions, it aims to provide both theoretical and practical guidance for translating QDs from laboratory-scale innovations into routine clinical practice.

Indexed as

Biosensing TechniquesPhototherapyQuantum DotsAnimalsHumansNeoplasmsPhotoacoustic TechniquesSignal Transductionbioimagingbiomedical applicationsbiosensingcancer treatmentsquantum dots

Identifiers

PMID42059327
PMCPMC13271630

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.